{"entity":{"id":"paper-mailankody-jama-oncol","kind":"paper","name":"Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs","aka":[],"tldr":"Paper cited by one bottleneck page, indexed on Europe PMC as PubMed record 26181265 and published in JAMA Oncology; the citing page links this DOI, which is how the record was matched.","summary":"Europe PMC indexes no abstract for this record; the title is the only text available.\n\nIndexed on Europe PMC as PubMed record 26181265 (DOI 10.1001/jamaoncol.2015.0373). Matched by DOI alone: one bottleneck page cites this DOI among its external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.","asOf":"2026-09-22","links":[{"label":"JAMA Oncol 2015","url":"https://doi.org/10.1001/jamaoncol.2015.0373"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/26181265/"},{"label":"Europe PMC","url":"https://europepmc.org/article/MED/26181265"}],"tags":["europepmc-ingest"],"related":["b-incentive-misalignment"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["jama-oncology"],"dependsOn":[],"notes":[],"journal":"JAMA Oncology","year":2015,"doi":"10.1001/jamaoncol.2015.0373","pmid":"26181265","authors":"Mailankody S, Prasad V","paperType":"observational","findings":[],"whatItMeans":"One bottleneck page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.","caveats":["Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper."]},"route":"/key-papers/paper-mailankody-jama-oncol/","neighbours":{"bottleneck":[{"id":"b-incentive-misalignment","kind":"bottleneck","name":"Incentives reward me-too drugs and marginal gains","route":"/bottlenecks/b-incentive-misalignment/"}],"journal":[{"id":"jama-oncology","kind":"journal","name":"JAMA Oncology","route":"/journals/jama-oncology/"}]}}